Researchers Combined Efforts Will Hopefully Lead To Improved Recognition Of Clostridioides difficile Pathogen To Reduce the Suffering and Economic Losses Caused by a CDI

Clostridioides difficile Infection: The Challenge, Tests, and Guidelines

 

Abstract

Clostridioides difficile is a dangerous human pathogen because it can grow to high numbers in the intestine, cause colitis with its potent toxins, and persist as spores. C. difficile infection (CDI) is the primary hospital-acquired infection in North America and Europe, and it now is a global disease. Even with newer laboratory tests, there still is confusion on accurately diagnosing this disease. Three guidelines from three different healthcare-affiliated societies have recently been published. Consensus consolidated recommendations from these guidelines should be recognized by healthcare professionals, who need to understand why this disease continues to be difficult to diagnose and need a clear understanding of the advantages and limitations of current tests. Hopefully, these combined efforts will lead to an improvement in the recognition of this pathogen and a reduction in the suffering and economic loss caused by CDI.

 

 

 

To review the publication in its entirety please click on the link below to be redirected:

https://pubmed.ncbi.nlm.nih.gov/32960044/